Shih‐Jen Liu

Kaohsiung Medical University — Taiwan

Immunology and Microbiology · Life Sciences

30h-index3.4kcitations128works11.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(59), SARS-CoV-2 and COVID-19 Research(24), Immune Response and Inflammation(18), Immune Cell Function and Interaction(16), RNA Interference and Gene Delivery(15)

Publications128 total

Lipid nanoparticle-formulated DNA acts as a potent immune modulator for cancer immunotherapy through interferon signaling pathways
Theranostics·2025Open Access
Advances in nucleic acid-based cancer vaccines
Journal of Biomedical Science·2025· 22 citedOpen Access
Boosting DNA vaccine power by lipid nanoparticles surface engineered with amphiphilic bioresorbable copolymer
Molecular Therapy — Nucleic Acids·2024· 8 citedOpen Access
SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters
Journal of Virology·2024· 1 citedOpen Access
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy
Nature Cancer·2024· 26 cited
Lipid nanoparticle-encapsulated DNA vaccine robustly induce superior immune responses to the mRNA vaccine in Syrian hamsters
Molecular Therapy — Methods & Clinical Development·2023· 27 citedOpen Access
A broad-spectrum pneumococcal vaccine induces mucosal immunity and protects against lethal <i>Streptococcus pneumoniae</i> challenge
Emerging Microbes & Infections·2023· 4 citedOpen Access
A TLR9 agonist synergistically enhances protective immunity induced by an Alum-adjuvanted H7N9 inactivated whole-virion vaccine
Emerging Microbes & Infections·2023· 10 citedOpen Access
Co‐delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1‐dominant humoral and cellular immunity against SARS‐CoV‐2
Journal of Medical Virology·2023· 4 citedOpen Access
Recombinant lipidated FLIPr effectively enhances mucosal and systemic immune responses for various vaccine types
npj Vaccines·2023· 4 citedOpen Access
ADAM9 drives immunosuppressive environment for lung tumor progression
The Journal of Immunology·2023· 1 citedOpen Access
Data from Cancer-Targeted BikDD Gene Therapy Elicits Protective Antitumor Immunity against Lung Cancer
2023Open Access
Supplementary Figure 2 from Cancer-Targeted BikDD Gene Therapy Elicits Protective Antitumor Immunity against Lung Cancer
2023Open Access
Supplementary Figure 1 from Cancer-Targeted BikDD Gene Therapy Elicits Protective Antitumor Immunity against Lung Cancer
2023Open Access
Supplementary Figure 1 from Cancer-Targeted BikDD Gene Therapy Elicits Protective Antitumor Immunity against Lung Cancer
2023Open Access
Data from Cancer-Targeted BikDD Gene Therapy Elicits Protective Antitumor Immunity against Lung Cancer
2023Open Access
Supplementary Figure 2 from Cancer-Targeted BikDD Gene Therapy Elicits Protective Antitumor Immunity against Lung Cancer
2023Open Access
Humoral and cellular immunity in three different types of COVID-19 vaccines against SARS-CoV-2 variants in a real-world data analysis
Journal of Microbiology Immunology and Infection·2023· 13 citedOpen Access
A flexible liposomal polymer complex as a platform of specific and regulable immune regulation for individual cancer immunotherapy
Journal of Experimental & Clinical Cancer Research·2023· 1 citedOpen Access
Correction: DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss
PLoS neglected tropical diseases·2023· 1 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Pele Chong(28), Hsin–Wei Chen(22), Chih‐Hsiang Leng(17), Mei‐Yu Chen(11), Kuan‐Yin Shen(8), Ming‐Hsi Huang(8), Jy-Ping Tsai(7), Hsueh‐Hung Liu(7), Chen-Yi Chiang(7), Ai‐Hsiang Chou(6), Chia‐Chyi Liu(5), Yuh‐Pyng Sher(5), Hung‐Chun Liao(5), Ai-Hsiang Chou(4), Shu-Pei Lien(4), Yen‐Hung Chow(4), Shu‐Pei Lien(4), Li‐Sheng Chang(4), Fang‐Feng Chiu(4), Ying Song(4)